Haemanalytica Ltd

Startup

Personalised medicine will transform the prevention and treatment of heart attacks, strokes, and bleeding disorders such as ITP; the current one-size-fits-all approach is imprecise and often fails.  HaemAnalytica provides next-generation platelet analysis, enhancing clinical trials and optimising treatment for more effective patient care, reduced costs, and improved health outcomes.